|
시장보고서
상품코드
2078655
체외진단(IVD) 시장(2026-2030년)Global In-Vitro Diagnostics (IVD) Market 2026-2030 |
||||||
세계의 체외진단(IVD) 시장은 2025-2030년 290억 9,690만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 4.5%를 기록할 것으로 예측됩니다.
본 보고서에서는 전 세계 체외진단(IVD) 시장에 대해 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체에 대한 분석을 제공합니다.
본 보고서에서는 현재 시장 상황, 최신 동향 및 성장요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장은 전 세계적으로 만성 질환 및 감염병 유병률이 증가하고, 맞춤형 의료와 동반 진단이 임상 현장에서 더욱 널리 채택되며, AI 및 검사실 자동화 시스템의 통합이 가속화됨에 따라 주도되고 있습니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 정보와 2차 정보를 객관적으로 종합하여 실시되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문별 데이터, 그리고 공급업체 현황이 수록되어 있습니다. 이 보고서에는 시장 규모 분석 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준연도 | 2025년 |
| 종료연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| YOY 2026 | 4.4% |
| CAGR | 4.5% |
| 증가액 | 290억 9,690만 달러 |
본 조사에서는 주요 지역 간 규제 준수 현황의 구조적 격차가 향후 몇 년간 전 세계 체외진단용 의약품(IVD) 시장의 성장을 견인할 주요 요인 중 하나라고 파악하고 있습니다. 또한, POC(현장) 검사 및 모바일 인프라를 통한 진단의 분산화와 더불어, 고처리량 분자진단 및 차세대 염기서열 분석의 보급으로 인해 시장에서 상당한 수요가 발생할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 제품 유형별
제9장 시장 세분화 : 기술별
제10장 시장 세분화 : 용도별
제11장 시장 세분화 : 최종사용자별
제12장 고객 현황
제13장 지역별 상황
제14장 성장 촉진요인, 과제 및 기회
제15장 경쟁 구도
제16장 경쟁 분석
제17장 부록
LSH 26.07.08The global in-vitro diagnostics (IVD) market is forecasted to grow by USD 29096.9 mn during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global in-vitro diagnostics (IVD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of chronic and infectious diseases, increasing clinical adoption of personalized medicine and companion diagnostics, accelerated integration of ai and laboratory automation systems.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 4.4% |
| CAGR | 4.5% |
| Incremental Value | $29096.9 mn |
Technavio's global in-vitro diagnostics (IVD) market is segmented as below:
By Product Type
- Reagents and kits
- Instruments
- Others
By Technology
- Immunoassay
- Molecular diagnostics
- Clinical chemistry
- Hematology
- Others
By Application
- Oncology
- Cardiology
- Autoimmune diseases
- Neurology
- Others
By End-User
- Hospitals and clinics
- Research institutes
- Diagnostics laboratories
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the structural staggering of regulatory conformity across major geographic regions as one of the prime reasons driving the global in-vitro diagnostics (IVD) market growth during the next few years. Also, decentralization of diagnostics through poc testing and mobile infrastructures and proliferation of high-throughput molecular diagnostics and next-generation sequencing will lead to sizable demand in the market.
The report on the global in-vitro diagnostics (IVD) market covers the following areas:
- Global in-vitro diagnostics (IVD) market sizing
- Global in-vitro diagnostics (IVD) market forecast
- Global in-vitro diagnostics (IVD) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global in-vitro diagnostics (IVD) market vendors that include Abbott Laboratories, ARKRAY Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., Grifols SA, Illumina Inc., QIAGEN N.V., QuidelOrtho Corp., Randox Laboratories Ltd., Seegene Inc., Sekisui Diagnostics LLC, Shenzhen Mindray Co. Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc.. Also, the global in-vitro diagnostics (IVD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global In-Vitro Diagnostics (IVD) Market 2020 - 2024
- Historic Market Size - Data Table on Global In-Vitro Diagnostics (IVD) Market 2020 - 2024 ($ million)
- 5.2 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- 5.3 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.6 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.7 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global in-vitro diagnostics (IVD) market
- 6.2 Impact of geopolitical conflicts on global in-vitro diagnostics (IVD) market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product Type
- 8.1 Market segments
- 8.2 Comparison by Product Type
- 8.3 Reagents and kits - Market size and forecast 2025-2030
- 8.4 Instruments - Market size and forecast 2025-2030
- 8.5 Others - Market size and forecast 2025-2030
- 8.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
9 Market Segmentation by Technology
- 9.1 Market segments
- 9.2 Comparison by Technology
- 9.3 Immunoassay - Market size and forecast 2025-2030
- 9.4 Molecular diagnostics - Market size and forecast 2025-2030
- 9.5 Clinical chemistry - Market size and forecast 2025-2030
- 9.6 Hematology - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Oncology - Market size and forecast 2025-2030
- 10.4 Cardiology - Market size and forecast 2025-2030
- 10.5 Autoimmune diseases - Market size and forecast 2025-2030
- 10.6 Neurology - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Market Segmentation by End-user
- 11.1 Market segments
- 11.2 Comparison by End-user
- 11.3 Hospitals and clinics - Market size and forecast 2025-2030
- 11.4 Research institutes - Market size and forecast 2025-2030
- 11.5 Diagnostics laboratories - Market size and forecast 2025-2030
- 11.6 Others - Market size and forecast 2025-2030
- 11.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- 13.2 Geographic comparison
- 13.3 North America - Market size and forecast 2025-2030
- 13.3.1 US - Market size and forecast 2025-2030
- 13.3.2 Canada - Market size and forecast 2025-2030
- 13.3.3 Mexico - Market size and forecast 2025-2030
- 13.4 Europe - Market size and forecast 2025-2030
- 13.4.1 Germany - Market size and forecast 2025-2030
- 13.4.2 UK - Market size and forecast 2025-2030
- 13.4.3 France - Market size and forecast 2025-2030
- 13.4.4 Italy - Market size and forecast 2025-2030
- 13.4.5 Spain - Market size and forecast 2025-2030
- 13.4.6 The Netherlands - Market size and forecast 2025-2030
- 13.5 Asia - Market size and forecast 2025-2030
- 13.5.1 China - Market size and forecast 2025-2030
- 13.5.2 India - Market size and forecast 2025-2030
- 13.5.3 Japan - Market size and forecast 2025-2030
- 13.5.4 South Korea - Market size and forecast 2025-2030
- 13.5.5 Indonesia - Market size and forecast 2025-2030
- 13.5.6 Thailand - Market size and forecast 2025-2030
- 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 13.6.1 Brazil - Market size and forecast 2025-2030
- 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 13.6.3 South Africa - Market size and forecast 2025-2030
- 13.6.4 UAE - Market size and forecast 2025-2030
- 13.6.5 Argentina - Market size and forecast 2025-2030
- 13.6.6 Colombia - Market size and forecast 2025-2030
- 13.6.7 Turkey - Market size and forecast 2025-2030
- 13.6.8 Israel - Market size and forecast 2025-2030
- 13.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
- 14.1 Market drivers
- Rising global prevalence of chronic and infectious diseases
- Increasing clinical adoption of personalized medicine and companion diagnostics
- Accelerated integration of AI and laboratory automation systems
- 14.2 Market challenges
- Escalating regulatory compliance pressures and compliance bottlenecks
- Inconsistent and unfavorable reimbursement frameworks across core testing categories
- Widespread deficits of skilled laboratory professionals and operational friction
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 14.4 Market opportunities
- Structural staggering of regulatory conformity across major geographic regions
- Decentralization of diagnostics through POC testing and mobile infrastructures
- Proliferation of high-throughput molecular diagnostics and next-generation sequencing
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- Companies covered
- 16.2 Company ranking index
- Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 16.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 16.7 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 16.8 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 16.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.10 FUJIFILM Holdings Corp.
- FUJIFILM Holdings Corp. - Overview
- FUJIFILM Holdings Corp. - Business segments
- FUJIFILM Holdings Corp. - Key news
- FUJIFILM Holdings Corp. - Key offerings
- FUJIFILM Holdings Corp. - Segment focus
- SWOT
- 16.11 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 16.12 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 16.13 Randox Laboratories Ltd.
- Randox Laboratories Ltd. - Overview
- Randox Laboratories Ltd. - Product / Service
- Randox Laboratories Ltd. - Key offerings
- SWOT
- 16.14 Sekisui Diagnostics LLC
- Sekisui Diagnostics LLC - Overview
- Sekisui Diagnostics LLC - Product / Service
- Sekisui Diagnostics LLC - Key offerings
- SWOT
- 16.15 Shenzhen Mindray Co. Ltd.
- Shenzhen Mindray Co. Ltd. - Overview
- Shenzhen Mindray Co. Ltd. - Business segments
- Shenzhen Mindray Co. Ltd. - Key offerings
- Shenzhen Mindray Co. Ltd. - Segment focus
- SWOT
- 16.16 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
- SWOT
- 16.17 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
- SWOT
- 16.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- Research methodology
- 17.5 Data procurement
- Information sources
- 17.6 Data validation
- Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
- List of abbreviations
